Handelsbanken Fonder’s Enanta Pharmaceuticals ENTA Stock Holding History

Handelsbanken Fonder’s Portfolio ENTA Stock Details ENTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-4,300	Closed	-$200K	–	1567
2022 Q4	$200K	Hold	4,300	–	–	﹤0.01%	1439
2022 Q3	$223K	Hold	4,300	–	–	﹤0.01%	1399
2022 Q2	$203K	Hold	4,300	–	–	﹤0.01%	1494
2022 Q1	$306K	Sell	4,300 -2,200	-34%	-$143K	﹤0.01%	1509
2021 Q4	$486K	Sell	6,500 -600	-8%	-$47.1K	﹤0.01%	1369
2021 Q3	$403K	Buy	7,100 +1,600	+29%	+$79.1K	﹤0.01%	1478
2021 Q2	$242K	Buy	+5,500	New	+$269K	﹤0.01%	1672

Other funds holding ENTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Handelsbanken Fonder's ENTA Position: Q1 2023 in Review

Handelsbanken Fonder sold out of Enanta Pharmaceuticals (ENTA) in Q1 2023, closing a stake of 4,300 shares — an estimated $200K sold.

Handelsbanken Fonder first reported a position in ENTA in Q2 2021 and held it in 7 quarters. The position peaked at $486K in Q4 2021. 144 funds tracked by Wall St. Rank hold ENTA as of Q1 2023.

Handelsbanken Fonder reported no remaining Enanta Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
Handelsbanken Fonder sold 4,300 Enanta Pharmaceuticals shares in Q1 2023, an estimated $200K.
Handelsbanken Fonder first reported a position in Enanta Pharmaceuticals in Q2 2021 and held it in 7 quarters.
Handelsbanken Fonder's Enanta Pharmaceuticals position peaked at $486K in Q4 2021.
144 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2023.

Based on Handelsbanken Fonder's 13F filing for Q1 2023, filed 28 Apr 2023.